arctoris.comCrawled Oct 15, 2026
Arctoris provides biologics discovery services, including antibody generation, engineering, functional characterization, and optimization, using its Ulysses platform.
Arctoris provides biophysics services to evaluate molecular interactions, including binary and ternary systems, and generate data for drug discovery.
Arctoris provides cell biology services to validate target engagement and assess functional activity in cellular systems.
Arctoris produces, purifies, and characterizes proteins for biochemical, biophysical, and structural studies.
The page describes how foundation models learn patterns across chemical and biological data and are being applied to drug discovery.
Arctoris is featured as a series partner in Biology for a Better Tomorrow, a digital series created with the Royal Society of Biology about how biological sciences address global challenges.
The page discusses the need for scalable phenotypic data compatible with high-throughput, AI/ML-driven analysis and notes that conventional RNA-seq workflows are difficult to scale.
The page describes macrocycles’ structural and conformational properties, including how their cyclic architectures combine conformational rigidity with three-dimensional complexity and can enable strong binding to biological targets.
A Drug Discovery World webinar featuring Arctoris discusses automated experimentation platforms and their use in drug discovery, including during the COVID-19 pandemic.
Fierce Biotech reported on Arctoris’s growth and executive team, including co-founder Tom Fleming’s appointment as CEO, succeeding co-founder Martin-Immanuel Bittner.
Labiotech reported on a collaboration between Arctoris and Molecule to combine laboratory automation with digital tools for sharing and developing drug intellectual property.
A Royal Society of Biology video features Arctoris and examines how technological innovation is changing drug discovery, including the challenges of traditional pharmaceutical R&D and the use of laboratory automation.
Arctoris says it is scaling and lists open roles.
Arctoris describes its drug discovery work as automated and its workplace as inclusive, friendly, and scientifically rigorous.
The page lists a full-time position at Milton Park, Arctoris’s UK headquarters.
The Chief People Officer page describes Arctoris as a team of scientists and problem-solvers and discusses the company’s workplace culture.
Arctoris was founded to solve a fundamental problem in drug discovery: biology has not kept pace with the scale, rigor, and data quality modern science demands.
The company combines robotics, data science, and deep biological expertise to generate precise, reproducible, and AI-ready data for discovering new medicines.
Arctoris Limited’s privacy policy describes how the company collects and uses personal data when people access its platforms, websites, and experimental, analytical, and computational services.
